Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dosing in obesity: a simple solution to a big problem.

P Y Han1, S B Duffull, C M J Kirkpatrick

  • 1School of Pharmacy, University of Queensland, Brisbane, Queensland, Australia.

Clinical Pharmacology and Therapeutics
|October 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-traumatic stress disorder cases reported by UK occupational physicians 1996-2024.

Occupational medicine (Oxford, England)·2026
Same author

Spinal Epidural Abscess Without Fever: Challenging the Classic Triad.

Irish medical journal·2024
Same author

Comparison of the survival of different isolates of SARS-CoV-2 in evaporating aerosols.

Aerosol science and technology : the journal of the American Association for Aerosol Research·2023
Same author

Pulse- and field-resolved THz-diagnostics at 4 <sup></sup> generation lightsources.

Optics express·2019
Same author

Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention.

The Journal of antimicrobial chemotherapy·2019
Same author

Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.

Scientific reports·2019
Same journal

The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient.

Clinical pharmacology and therapeutics·2026
Same journal

Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

Clinical pharmacology and therapeutics·2026
Same journal

Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.

Clinical pharmacology and therapeutics·2026
Same journal

Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

Clinical pharmacology and therapeutics·2026
Same journal

Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

Clinical pharmacology and therapeutics·2026
Same journal

Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

Clinical pharmacology and therapeutics·2026
See all related articles

Obesity impacts drug effectiveness, but dosing guidelines are unclear. This study introduces a lean body weight (LBW) model to adjust medication clearance for obese patients, improving chronic dosing strategies.

Area of Science:

  • Pharmacology
  • Obesity Research
  • Pharmacokinetics

Background:

  • The global obesity epidemic increases chronic diseases, necessitating pharmacological interventions.
  • Obesity's influence on drug exposure and dosing remains poorly understood, lacking clear guidelines for obese individuals.

Purpose of the Study:

  • To develop a robust model for quantifying the impact of body composition on drug clearance.
  • To establish lean body weight (LBW) as a reliable metric for adjusting chronic drug dosing in obese populations.

Main Methods:

  • Development of a semi-mechanistic model focused on lean body weight (LBW).
  • Validation of the model's robustness in assessing body composition's effect on drug clearance.

Main Results:

Related Experiment Videos

  • The proposed LBW model effectively quantifies the influence of body composition on drug clearance.
  • The model demonstrates suitability for optimizing chronic dosing in obese patients.

Conclusions:

  • Lean body weight (LBW) is a key metric for personalizing drug dosage in obese individuals.
  • This modeling approach offers a pathway to improved therapeutic outcomes and safer medication use in obesity.